Tectonic Therapeutic, Inc.
TECX
$32.60
-$0.71-2.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.03% | -6.71% | 18.40% | 144.74% | 121.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.78% | 11.47% | 95.53% | 41.10% | 49.25% |
| Operating Income | -53.78% | -11.47% | -95.53% | -41.10% | -49.25% |
| Income Before Tax | -53.33% | -7.44% | -50.01% | -4.50% | -57.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.39% | -7.44% | -57.71% | -4.50% | -57.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.39% | -7.44% | -57.71% | -4.50% | -57.24% |
| EBIT | -53.78% | -11.47% | -95.53% | -41.10% | -49.25% |
| EBITDA | -57.11% | -12.15% | -98.39% | -42.47% | -49.79% |
| EPS Basic | -22.80% | 15.44% | 75.35% | 91.55% | 85.79% |
| Normalized Basic EPS | -21.17% | 15.43% | 76.55% | 91.55% | 85.79% |
| EPS Diluted | -22.80% | 15.44% | 75.35% | 91.55% | 85.79% |
| Normalized Diluted EPS | -21.17% | 15.43% | 76.55% | 91.55% | 85.79% |
| Average Basic Shares Outstanding | 26.54% | 27.05% | 539.75% | 1,136.77% | 1,006.57% |
| Average Diluted Shares Outstanding | 26.54% | 27.05% | 539.75% | 1,136.77% | 1,006.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |